Details of CPPsite entry with Sequence B-GLRK(NIA)RLRKFRNKIKEK |
Primary information | |
---|---|
PEPTIDE SEQUENCE | B-GLRK(NIA)RLRKFRNKIKEK |
CPPsite ID | 2602, 2604, |
PEPTIDE NAME | CF-sC18(NIA), DOTA-sC18(NIA) |
CHIRALITY | Modified, Modified |
LINEAR/CYCLIC | Linear, Linear |
SOURCE | Synthetic, Synthetic |
CATEGORY | NA, NA |
SUB CELLULAR LOCALIZATION | Cytoplasmic Vesicles, NA |
N-TERMINAL MODIFICATION | Amidation, Amidation |
C-TERMINAL MODIFICATION | NA, NA |
CHEMICAL MODIFICATION | B, Beta-Alanine; NIA, 2-(2-nitroimidazol-1-yl)acetic acid, B, Beta-Alanine; NIA, 2-(2-nitroimidazol-1-yl)acetic acid ; N terminal chelator DOTA(1,4,7,10-tetraaza-cyclododecane-1,4,7,10-tetraacetic acid) |
UPTAKE EFFICIENCY | NA, NA |
PROPOSED UPTAKE MECHANISM | Endocytic pathway, NA |
INVITRO/INVIVO | In vitro, In vivo |
CELL LINE | MCF-7 cells, NA |
In VIVO MODEL | NA, Wistar rats, four female NMRI (nu/nu) mice |
CARGO | Fluorophore (Carboxyfluorescein), Radioactive copper |
PMID | 21956822, 21956822 |
PATENT | Unknown, Unknown |
Tertiary Structure (Technique) | Not Predicted), Not Predicted), |